Position in SNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,439,697
-$2,243,639 QoQ
Shares Held
291,601
-4.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#76
of 712 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $2,503,359,774 across 18 Drug Manufacturers - General names. SNY ranks #13 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
692,569 | $830,688,102 | |
| 2 | JNJ |
Johnson & Johnson
|
1,312,753 | $333,399,877 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,433,801 | $312,743,428 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,946,858 | $245,966,038 | |
| 5 | ABBV |
AbbVie Inc.
|
850,973 | $214,138,842 | |
| 6 | AMGN |
Amgen Inc
|
430,230 | $155,794,886 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,580,079 | $148,664,149 | |
| 8 | AZN |
Astrazeneca PLC
|
447,620 | $84,877,702 |
All Filings in SNY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,439,697 | 291,601 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $14,683,336 | 304,760 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,825,444 | 285,296 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,651,163 | 310,406 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,987,790 | 310,242 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $16,737,772 | 301,799 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $14,658,736 | 303,934 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $17,164,807 | 297,845 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $17,391,508 | 358,440 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $17,053,497 | 350,895 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $16,853,447 | 338,899 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $17,915,223 | 333,990 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $18,926,822 | 351,147 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $18,216,441 | 334,738 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $12,475,955 | 257,608 | Shares | Defined | 2023-01-24 | |
| 2022-09-30 | $9,865,885 | 259,492 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $13,259,951 | 265,040 | Shares | Defined | 2022-07-28 | |
| 2022-03-31 | $13,494,719 | 262,850 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $13,082,262 | 261,123 | Shares | Defined | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||